Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;72(3):e31484.
doi: 10.1002/pbc.31484. Epub 2024 Dec 17.

Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts

Hailey S Ross  1 , Ronald H Dallas  1 , Jose A Ferrolino  1 , Madeline B Johnson  1 , Kim J Allison  1 , Shane J Cross  2 , Randall T Hayden  3 , Asuncion Mejias  1 , Diego R Hijano  1   4
Affiliations

Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts

Hailey S Ross et al. Pediatr Blood Cancer. 2025 Mar.

Abstract

Background: Pediatric immunocompromised patients are at an increased risk of severe respiratory syncytial virus (RSV) infection. Here, we aimed to describe the clinical course and outcomes of RSV infection in immunocompromised children.

Methods: This single-center study at St. Jude Children's Research Hospital involved immunocompromised children ≤21 years old with a positive RSV clinical test from 2007 to 2019. Demographic and clinical characteristics, laboratory values, treatment delays for underlying conditions, and outcomes were gathered from electronic medical records. Multivariate models identified risk factors predictive of severe RSV-lower respiratory tract infection (LRTI).

Results: A total of 391 patients, predominantly children over 2 years old (median age: 5), were included in the study. Acute lymphoblastic leukemia (ALL) was the most prevalent underlying disease. Most patients (85.7%) exhibited upper respiratory tract infections, while approximately 6% progressed to LRTIs. Over half of the patients (58.8%) required hospitalization, and one-third experienced modifications or delays in their underlying disease treatment due to RSV infection. Severe RSV infections were observed in 15.9% of patients. All-cause mortality was 2.6%, with 0.7% of deaths attributed to RSV.

Conclusions: One-third of patients experienced a delay in treatment for their underlying disease due to RSV infection, a phenomenon not well understood but potentially significant. Many immunocompromised children with RSV require hospitalization, including those over 2 years old. RSV imposes a significant burden on immunocompromised children of all ages, affecting their cancer treatment plans both directly and indirectly.

Keywords: RSV; cancer; chemotherapy; hematopoietic cell transplant; hospitalization.

PubMed Disclaimer

References

    1. J. S. Tregoning and J. Schwarze, “Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology,” Clinical Microbiology Reviews 23, no. 1 (2010): 74–98, https://doi.org/10.1128/CMR.00032‐09.
    1. H. C. Meissner, “Viral Bronchiolitis in Children,” New England Journal of Medicine 374, no. 18 (2016): 1793–1794, https://doi.org/10.1056/NEJMc1601509.
    1. N. Soudani, M. A. Caniza, A. Assaf‐Casals, et al., “Prevalence and Characteristics of Acute Respiratory Virus Infections in Pediatric Cancer Patients,” Journal of Medical Virology 91, no. 7 (2019): 1191–1201, https://doi.org/10.1002/jmv.25432.
    1. R. F. Chemaly, S. S. Ghantoji, D. P. Shah, et al., “Respiratory Syncytial Virus Infections in Children with Cancer,” Journal of Pediatric Hematology/Oncology 36, no. 6 (2014): e376–e381, https://doi.org/10.1097/MPH.0000000000000086.
    1. D. Kumar and A. Humar, “Respiratory Viral Infections in Transplant and Oncology Patients,” Infectious Disease Clinics of North America 24, no. 2 (2010): 395–412, https://doi.org/10.1016/j.idc.2010.01.007.

MeSH terms

LinkOut - more resources